JP2017099512A - Magnetic resonance apparatus - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a magnetic resonance apparatus capable of acquiring a high-quality blood flow image when acquiring a blood flow image such as a perfusion image using an imaging method for labeling blood spins.SOLUTION: In a real scan MS, an imaging sequence including sequence segments Ai and Bi is performed. The sequence segment Ai includes: a labeling sequence SQ2; a sequence SQ3 having a pulse set Vincluding an RF pulse wand a gradient pulse Gz; and a data collection sequence DAQi for collecting data of an imaging area SB. The sequence segment Bi includes: a control sequence SQ20; a sequence SQ3 having a pulse set Vincluding an RF pulse wand a gradient pulse Gz; and a data collection sequence DAQi for collecting data of an imaging area SB.SELECTED DRAWING: Figure 14

Description

  The present invention relates to a magnetic resonance apparatus that labels blood spin.

As one imaging method for acquiring a blood flow image, an imaging method called ASL (Arterial Spin Labeling) is known. In this imaging, magnetic labeling is performed in advance on the spin on the upstream side of the blood flow of the subject, and a magnetic resonance signal generated by flowing the labeled spin into the region of interest is used for imaging. As a method of obtaining a blood flow image using the ASL method,
A method for obtaining a difference image between a label image that is a tomographic image with labeling and a control image that is a tomographic image without labeling is known (see, for example, Patent Document 1).

JP 2014-014399 A

Eun-Kee Jeong, Seong-Eun Kim and Dennis L. Parker.High-resolution diffusion-weighted 3D MRI, using diffusion-weighted driven-equilibrium (DW-DE) and multishot segmented 3D-SSFP without navigator echoes.Magn Reson Med. Volume 50, Issue 4, pages 821-829, October 2003.

  The ASL method is also applied to photographing for acquiring a perfusion image (perfusion image). In imaging for acquiring a perfusion image, blood flowing through a thin blood vessel such as a capillary blood vessel is drawn with a signal as high as possible, and blood flowing through a thick blood vessel is drawn with a signal as low as possible. However, the normal ASL method has a problem in that it is difficult to sufficiently reduce the signal of blood flowing through a thick blood vessel, and it is difficult to obtain a high-quality perfusion image. Therefore, in order to reduce a blood flow signal of a thick blood vessel that is not required when generating a perfusion image, a method using a DWDE (diffusion-weighted driven-equilibrium) sequence (see Non-Patent Document 1) is studied for the ASL method. ing.

  However, the method using the DWDE sequence has a problem that it is difficult to obtain a spatially uniform blood flow suppression effect due to B1 nonuniformity, and it is difficult to obtain a high-quality perfusion image.

  For this reason, when obtaining a blood flow image such as a perfusion image using an imaging method that labels blood spin, a technique capable of obtaining a high-quality blood flow image is desired.

One aspect of the present invention is a magnetic resonance apparatus for acquiring an image of a first region containing blood,
Setting means for setting a second region for labeling the spin of blood before blood flows into the first region;
Scanning means for executing an imaging sequence for acquiring an image of the first region,
A first sequence for labeling spins of blood in the second region;
A second sequence executed after the first sequence, the first RF pulse for exciting the first region and the phase of the spin of the first blood flowing through the first region To disperse the spin phase of the blood in the first region so that the spin phase of the second blood flowing through the first region at a slower flow rate than the first blood is dispersed. A second sequence having a plurality of first pulse sets including a first gradient pulse of:
A third sequence for collecting data of the first region after the second sequence is executed;
A first sequence segment that includes: a fourth sequence that does not label spins of blood in the second region;
A fifth sequence executed after the fourth sequence, the second RF pulse for exciting the first region and the phase of spin of the third blood flowing in the first region; To disperse the spin phase of the blood in the first region so that the spin phase of the fourth blood flowing through the first region at a slower flow rate than the third blood is dispersed. A fifth sequence having a plurality of second pulse sets including a second gradient pulse;
A sixth sequence for collecting data of the first region after the fifth sequence is executed;
A second sequence segment containing
Scanning means for executing an imaging sequence comprising:
A control unit for controlling the scanning means;
Image generating means for generating an image of the first region based on data obtained by executing the imaging sequence;
Have
The controller is
In the first sequence segment, the flip angle of the first RF pulse of each of the plurality of first pulse sets included in the second sequence has a value greater than 0 ° and less than 90 °;
In the second sequence segment, the flip angle of the second RF pulse of each of the plurality of second pulse sets included in the fifth sequence has a value larger than 0 ° and smaller than 90 °. A magnetic resonance apparatus for controlling the scanning means.

  Since the flip angle is set to a value smaller than 90 °, it is possible to reduce variation in blood suppression effect due to B1 nonuniformity of the RF pulse. Therefore, a high-quality blood flow image can be obtained.

It is the schematic of the magnetic resonance apparatus of one form of this invention. It is explanatory drawing of the means which the processing apparatus 9 implement | achieves. It is explanatory drawing of the scan performed with this form. It is a figure which shows the flow in this form. It is a figure which shows roughly an example of image LD acquired by the localizer scan LS. It is a figure which shows imaging region SB schematically. It is a figure which shows the labeling area | region SL roughly. It is explanatory drawing of this scan MS. It is explanatory drawing of sequence segment A1-Am. It is explanatory drawing of Pre Sat sequence SQ1. It is explanatory drawing of labeling sequence SQ2. It is explanatory drawing of an effect | action of labeling sequence SQ2. It is explanatory drawing of pulse set Inv1. It is explanatory drawing of sequence SQ3. It is a figure which shows the phase of RF pulse in the case of (phi) ₁ = 0 degree and (DELTA) phi = 0 degree. It is a figure which shows the phase of RF pulse in the case of (phi) ₁ = 0 degree and (DELTA) phi = 180 degree. It is a figure which shows the phase of RF pulse in the case of (phi) ₁ = 0 degree and (DELTA) phi = 45 degree. It is explanatory drawing of an effect | action of sequence SQ3. It is explanatory drawing of the signal obtained from the imaging area | region SB by performing the sequence segment Ai. It is explanatory drawing of sequence segment B1-Bm. It is explanatory drawing of control sequence SQ20. It is explanatory drawing of an effect | action of control sequence SQ20. It is explanatory drawing of the signal obtained from the imaging area | region SB by performing the sequence segment Bi. It is explanatory drawing of an example of the flow of step ST4. It is a figure which shows roughly the imaging data obtained by this scan MS. It is explanatory drawing of step ST42. It is a figure which shows the sequence segment Ai of this form, and the sequence segment Ai of a comparative example. It is a figure which shows the sequence segment Bi of this form, and the sequence segment Bi of a comparative example. It is explanatory drawing of the problem of a comparative example. It is a figure which shows the example which provided sequence SQ3 between pulse set Inv2 and the data acquisition sequence DAQi. FIG. 10 is a diagram illustrating an example in which two sequences SQ3 are included in each of sequence segments Ai and Bi.

  Hereinafter, although the form for inventing is demonstrated, this invention is not limited to the following forms.

FIG. 1 is a schematic view of a magnetic resonance apparatus according to one embodiment of the present invention.
A magnetic resonance apparatus (hereinafter referred to as “MR apparatus”. MR: Magnetic Resonance) 1 has a magnet 2, a table 3, a reception RF coil (hereinafter referred to as “reception coil”) 4, and the like.

  The magnet 2 has an accommodation space 21 in which the subject 13 is accommodated. The magnet 2 includes a superconducting coil 22, a gradient coil 23, and an RF coil 24. The superconducting coil 22 applies a static magnetic field, the gradient coil 23 applies a gradient pulse, and the RF coil 24 applies an RF pulse. In place of the superconducting coil 22, a permanent magnet may be used.

  The table 3 has a cradle 3 a for transporting the subject 13. The subject 13 is transported to the accommodation space 21 by the cradle 3a.

  The receiving coil 4 is attached to the head of the subject 13 and receives a magnetic resonance signal from the subject 13.

  The MR apparatus 1 further includes a control unit 5, a transmitter 6, a gradient magnetic field power source 7, a receiver 8, a processing device 9, a storage unit 10, an operation unit 11, a display unit 12, and the like.

  The control unit 5 receives data including waveform information and application timing of RF pulses and gradient pulses used in the sequence from the processing device 9. Then, the controller 5 controls the transmitter 6 based on the RF pulse data, and controls the gradient magnetic field power source 7 based on the gradient pulse data. The control unit 5 also controls the movement of the cradle 3a. In FIG. 1, the control unit 5 controls the transmitter 6, the gradient magnetic field power supply 7, the cradle 3 a, etc. However, the control of the transmitter 6, the gradient magnetic field power supply 7, the cradle 3 a, etc. You may go on. For example, you may provide separately the control part which controls the transmitter 6 and the gradient magnetic field power supply 7, and the control part which controls the cradle 3a.

The transmitter 6 supplies current to the RF coil 24 based on the data received from the control unit 5.
The gradient magnetic field power supply 7 supplies a current to the gradient coil 23 based on the data received from the control unit 5.

  The receiver 8 performs processing such as detection on the magnetic resonance signal received by the receiving coil 4 and outputs the processed signal to the processing device 9. A combination of the magnet 2, the receiving coil 4, the transmitter 6, the gradient magnetic field power source 7, and the receiver 8 corresponds to the scanning means.

  The storage unit 10 stores a program executed by the processing device 9 and the like. The storage unit 10 may be a non-transitory storage medium such as a hard disk or a CD-ROM. The processing device 9 operates as a processor that reads a program stored in the storage unit 10 and executes a process described in the program. The processing device 9 implements various means by executing processing described in the program. FIG. 2 is an explanatory diagram of means realized by the processing device 9.

The image generation unit 91 generates an image based on data obtained by scanning.
The setting unit 92 sets an imaging region for acquiring an image of the imaging region, and sets a labeling region for labeling blood spins based on positional information of the imaging region. The imaging area corresponds to the first area, and the labeling area corresponds to the second area.

The MR apparatus 1 includes a computer including a processing device 9. The processing device 9 implements an image creating unit 91, a setting unit 92, and the like by reading a program stored in the storage unit 10. The processing device 9 may implement the image creating unit 91 and the setting unit 92 with one processor, or may implement the image creating unit 91 and the setting unit 92 with two or more processors. Further, one of the image creating unit 91 and the setting unit 92 may be executed by the control unit 5. Further, the program executed by the processing device 9 may be stored in one storage unit, or may be stored in a plurality of storage units.
Returning to FIG. 1, the description will be continued.

The operation unit 11 is operated by an operator and inputs various information to the computer 8. The display unit 12 displays various information.
The MR apparatus 1 is configured as described above.

FIG. 3 is an explanatory diagram of the scan executed in this embodiment.
In the first mode, a localized scan LS, a main scan MS, and the like are executed.

  The localizer scan LS is a scan for acquiring an image LD used for setting an imaging region SB (see FIG. 6) described later. The main scan MS is a scan for acquiring a perfusion image of the imaging region SB.

  Hereinafter, a flow for executing these scans and acquiring a perfusion image will be described with reference to FIG.

FIG. 4 is a diagram showing a flow in this embodiment.
In step ST1, a localizer scan LS is executed. The image generation unit 91 (see FIG. 2) generates an axial image, a sagittal image, and a coronal image based on the data obtained by the localizer scan LS. FIG. 5 is a diagram schematically showing an example of an image LD acquired by the localizer scan LS. FIG. 5 shows a sagittal image. In FIG. 5, the RL (Right-Left) direction represents the left-right direction, the AP (Anterior-Posterior) direction represents the front-rear direction, and the SI (Superior-Inferior) direction represents the head-to-tail direction. After performing the localizer scan LS, the process proceeds to step ST2.

  In step ST2, the operator sets an imaging region SB for acquiring an image of the imaging region based on the image LD. The operator operates the operation unit 11 and inputs information for setting the imaging region SB. When this information is input, the setting unit 92 (see FIG. 2) sets the imaging region SB in the imaging region based on the input information. FIG. 6 schematically shows the set imaging region SB. In this embodiment, since it is considered to acquire a perfusion image of blood flowing through the brain, the imaging region SB is set so as to include the brain. After setting the imaging region SB, the process proceeds to step ST3.

  In step ST3, the setting unit 92 sets a labeling region SL for labeling blood spins in a labeling sequence SQ2 (see FIG. 11), which will be described later, based on the position information of the imaging region SB. The setting unit 92 sets the labeling region SL at a position separated from the position of the I side end of the imaging region SB by a distance d on the I side. FIG. 7 schematically shows the set labeling region SL. d is, for example, d = 2 cm. Further, the thickness (slice thickness) of the labeling region SL in the SI direction is, for example, several mm. The operator may manually set the labeling area SL.

  In FIG. 7, blood flowing in the labeling region SL is indicated by reference sign “b0”, and blood flowing in the imaging region SB is indicated by reference signs “b1” and “b2”. The blood b1 in the imaging region SB is blood that flows through a thick blood vessel (for example, the internal carotid artery), and the blood b2 in the imaging region SB represents blood that flows through a thin blood vessel (for example, a capillary blood vessel). After setting the labeling area SL, the process proceeds to step ST4.

  In step ST4, a main scan MS for acquiring an image of the imaging region SB is executed. The main scan MS will be described below.

FIG. 8 is an explanatory diagram of the main scan MS.
In the main scan MS, an imaging sequence for acquiring an image of the imaging region SB is executed. The imaging sequence has sequence segments A1 to Am and sequence segments B1 to Bm. Hereinafter, the sequence segments A1 to Am and B1 to Bm will be described.

FIG. 9 is an explanatory diagram of the sequence segments A1 to Am.
In FIG. 9, the i-th sequence segment is indicated by Ai. i is an integer value of i = 1 to m. Therefore, for example, when i = 1, the sequence segment Ai represents the sequence segment A1, and when i = m, the sequence segment Ai represents the sequence segment Am.

  The sequence segment Ai has a Pre Sat sequence SQ1, a labeling sequence SQ2, a pulse set Inv1, a sequence SQ3, a pulse set Inv2, and a data acquisition sequence DAQi. Hereinafter, these sequences and pulse sets will be described in order.

FIG. 10 is an explanatory diagram of the Pre Sat sequence SQ1.
The Pre Sat sequence SQ1 is a sequence for reducing the magnetization of the tissue in the imaging region SB. The Pre Sat sequence SQ1 has a plurality of pulse sets PS1. The pulse set PS1 includes an RF pulse P1, a slice selection gradient pulse Gs1, and a crusher gradient pulse Gc. In the Pre Sat sequence SQ1, the pulse set PS1 is repeatedly executed.

  Here, the RF pulse P1 is a 90 ° pulse. The imaging region SB is selectively excited by the RF pulse P1 and the slice selective gradient pulse Gs1. Since the magnetization vector of the tissue in the imaging region SB falls by 90 ° by the RF pulse P1, the longitudinal magnetization of each tissue in the imaging region SB can be reduced. Further, by applying the crusher gradient pulse Gc, it is possible to disperse the phase of the transverse magnetization of the blood b1 and b2 flowing in the imaging region SB. Therefore, by executing the pulse set PS1, the magnitude of the magnetization of the tissue in the imaging region SB can be reduced. The time length of the Pre Sat sequence SQ1 can be several tens of msec (for example, 20 msec). After executing the Pre Sat sequence SQ1, the labeling sequence SQ2 is executed.

FIG. 11 is an explanatory diagram of the labeling sequence SQ2.
The labeling sequence SQ2 (corresponding to the first sequence) is a sequence for magnetically labeling spins of blood flowing through the labeling region SL. The labeling sequence SQ2 has a pulse set E1. In the labeling sequence SQ2, the pulset E1 is continuously and repeatedly executed.

  The pulse set E1 includes an RF pulse P21, a slice selection pulse Gs2, and a correction gradient pulse Gc2. 11 shows a coordinate system (a) for explaining the phase φa of the RF pulse P21. The z-axis represents the static magnetic field direction. In this embodiment, the axis (φa axis) representing the phase φa of the RF pulse P21 is set in the xy plane. Here, the φa axis is set to the x axis.

  The flip angle of the RF pulse P21 is represented by β. Therefore, when the RF pulse P21 is applied, the magnetization vector rotates about the φa axis (x axis) by the flip angle β. For example, when β = 12 °, the magnetization vector rotates β = 12 ° around the φa axis.

  The labeling region SL is excited by the RF pulse P21 and the slice selection pulse Gs2. Immediately after the excitation of the labeling region SL, a correction gradient pulse Gc2 for returning the spin phase shift is applied. In the labeling sequence SQ2, the pulse set E1 is repeatedly executed.

FIG. 12 is an explanatory diagram of the operation of the labeling sequence SQ2.
FIG. 12 schematically shows a coordinate system (c) for explaining the magnetization vector M of the labeling region SL immediately before the start of the labeling sequence SQ2. Immediately before the start of the labeling sequence SQ2, it is assumed that the magnetization vector M of the blood in the labeling region SL is oriented in the z-axis direction.

  When the pulse set E1 is executed, the RF pulse P21 causes the magnetization vector M of the blood in the labeling region SL to be flipped by β around the φa axis (x axis) (see coordinate system (a)). Therefore, the magnetization vector M is inclined by β with respect to the z-axis. After the pulse set E1 is executed, the next pulse set E1 is executed.

  When the next pulse set E1 is executed, the magnetization vector M is further inclined by β with respect to the z-axis by the RF pulse P21 (see the coordinate system (b)). Similarly, the pulse set E1 is repeatedly executed. Therefore, every time the pulse set E1 is executed, the magnetization vector of the blood in the labeling region SL is inclined by β, so that the longitudinal magnetization of the blood in the labeling region SL is reduced every time the pulse set E1 is executed. For this reason, by executing the labeling sequence SQ2, the spins of blood in the labeling region SL are labeled so that the longitudinal magnetization becomes small, and flow out of the labeling region SL. After executing the labeling sequence SQ2, the pulse set Inv1 is executed.

FIG. 13 is an explanatory diagram of the pulse set Inv1.
The pulse set Inv1 includes an RF pulse Pin for inverting the longitudinal magnetization of each tissue in the region R1 including the labeling region SL and the imaging region SB, and a selection gradient pulse Gin for selecting the region R1. By executing the pulse set Inv1, the region R1 is selectively excited, and the longitudinal magnetization of each tissue in the region R1 can be reversed. After executing the pulse set Inv1, the sequence SQ3 is executed.

FIG. 14 is an explanatory diagram of the sequence SQ3.
Sequence SQ3 (corresponding to the second sequence) is the magnetization of blood with a high flow rate without making the magnetization of blood with a slow flow rate as small as possible among the blood flowing through region R2 including labeling region SL and imaging region SB. The sequence is as small as possible. In FIG. 14, blood b1 represents blood flowing through a relatively thick blood vessel (for example, the internal carotid artery). Since the blood b1 is blood that flows through a relatively thick blood vessel, it is blood with a high flow rate. On the other hand, blood b2 represents blood flowing through the capillary. Since the capillary blood vessel is a thin blood vessel, the blood b2 flowing through the capillary blood vessel is blood having a low flow rate. Accordingly, the sequence SQ3 is a sequence in which the magnetization of blood (eg, blood b1) having a high flow rate is made as small as possible while the magnetization of blood (eg, blood b2) having a low flow rate among the blood flowing through the region R2 is made as small as possible. It is.

The sequence SQ3 will be specifically described below. The sequence SQ3 has a pulse set V _{1 to} V _n including an RF pulse and a gradient pulse.

The i-th executed pulse set V _i (i = 1 to n) is shown on the lower side of FIG.
The pulse set V _i includes an RF pulse w _i and a gradient pulse Gz. The RF pulse w _i is an excitation pulse for exciting the tissue in the region R2 including the labeling region SL and the imaging region SB. A coordinate system for explaining the phase φ _i of the RF pulse w _i is shown in the lower right of the pulse set V _i . The phase φ _i is expressed by the following equation.
φ _i = φ ₁ + (i−1) Δφ (1)

Δφ in Expression (1) is expressed by the phase φ _i−1 of the RF pulse w _i−1 included in the _i− 1th pulse set V _i−1 and the i th executed pulse set V _i . The phase difference from the phase φ _i of the included RF pulse w _i . In this embodiment, an axis at a position shifted by a phase φ _{i with} respect to the x axis is referred to as a φ _i axis. For i = 1, ie, the first pulse set V ₁ to be executed, the phase of the RF pulse w ₁ is φ ₁ . In i = 2, that is, in the second pulse set V ₂ to be executed, the phase of the RF pulse w ₂ is φ ₂ = φ ₁ + Δφ. Similarly, every time the value of i increases by 1, the phase φ _i of the RF pulse w _i increases by Δφ. Accordingly, i = j, that is, in the j-th pulse set V _j , the phase of the RF pulse w _j is φ _j = φ ₁ + (j−1) Δφ. Then, i = n, i.e., the pulse set _{V n} executed last, phase of the RF pulse _{w n} is _{φ n = φ 1 + (n} -1) Δφ.

Further, the flip angle of the RF pulse w _i is represented by α _i . Therefore, when the RF pulse w _i is applied, the magnetization vector rotates about the φ _i axis by the flip angle α _i .

For example, when φ ₁ = 0 ° and Δφ = 0 °, the phase of the RF pulse is expressed as shown in FIG. That is, the phases φ _{1 to} φ _n of the RF pulses w _{1 to} w _n are set to the same value (0 °). Accordingly, when the RF pulse _{w 1} is applied, the magnetization vector around the phi ₁ axis (x-axis), rotated by alpha _1. Similarly, when each of the RF pulses w _{2 to} w _n is applied, the magnetization vector rotates by α _{2 to} α _n about the x axis. α _i is set to satisfy 0 ° <α _i <90 °. For example, α _i = 12 °.

FIG. 16 shows the phase of the RF pulse when φ ₁ = 0 ° and Δφ = 180 °. In FIG. 16, the φ _i axis representing the phase of the RF pulse is set so that the x axis and the −x axis (axis shifted by 180 ° from the x axis) appear alternately.

Further, FIG. 17 shows the phase of the RF pulse when φ ₁ = 0 ° and Δφ = 45 °. In FIG. 17, the phase of the RF pulse is set to increase by 45 °.

FIG. 18 is an explanatory diagram of the operation of the sequence SQ3.
In a sequence SQ3, firstly, the pulse set _{V 1} is executed. The pulse set _{V 1,} RF pulses _{w 1} is applied. By applying the RF pulse w ₁ , the magnetization vector rotates α ₁ (0 ° <α ₁ <90 °) about the φ ₁ axis (φ ₁ = 0 °). Then, after the RF pulse w ₁ is applied, the gradient pulse Gz is applied. By applying the gradient pulse Gz, the phase of the magnetization vector is dispersed.

Similarly, the pulse sets V _{2 to} V _n are sequentially executed. Therefore, in the sequence SQ3, the gradient pulse Gz for dispersing the phase is repeatedly applied. Since the stationary tissue does not move while the sequence SQ3 is executed, the magnitude of the gradient pulse Gz applied to the stationary tissue is the same regardless of which pulse set is executed. Moreover, since the blood b2 flowing through the thin blood vessel has a low flow velocity, the moving distance of the blood b2 during the execution of the sequence SQ3 is short. Therefore, while the sequence SQ3 is being executed, the magnitude of the gradient pulse Gz applied to the blood b2 flowing through the thin blood vessel does not change much. On the other hand, since the blood b1 flowing through the thick blood vessel has a high flow velocity, the moving distance of the blood b1 during execution of the sequence SQ3 is long. Therefore, while the sequence SQ3 is being executed, the magnitude of the gradient pulse Gz applied to the blood b1 flowing through the thick blood vessel changes greatly with time. Therefore, by executing the sequence SQ3, the phase of the blood b1 flowing through the thick blood vessel can be dispersed as much as possible while the phase of the blood b2 flowing through the stationary tissue (for example, white matter or gray matter) or the thin blood vessel is dispersed as much as possible. it can. As a result, the blood b2 having a low flow rate can have a high signal, while the blood b1 having a high flow rate can have a low signal.

However, if the area of the gradient pulse Gz is too large, not only the blood b1 having a high flow rate but also the phase of the blood b2 having a low flow rate is sufficiently dispersed, so that both the blood b1 having a high flow rate and the blood b2 having a low flow rate are present. There is a risk of low signal. On the other hand, if the area of the gradient pulse Gz is too small, the phase of the blood b1 having a high flow rate is not dispersed so much that both the blood b2 having a low flow rate and the blood b1 having a high flow rate may have a high signal. Therefore, the area of the gradient pulse Gz is set so as to satisfy the following conditions (1) and (2).
(1) The phase of blood with a slow flow rate should not be dispersed as much as possible.
(2) Disperse the phase of blood with a high flow rate as much as possible.

  The area of the gradient pulse Gz that satisfies the above conditions (1) and (2) is determined in advance before imaging the subject. As a method for determining the area of the gradient pulse Gz, there is a method in which the scan is repeatedly executed while the area of the gradient pulse Gz of the sequence SQ3 is changed, and a plurality of images obtained by repeatedly executing the scan are referred to. . By referring to these plural images, it is possible to determine the area of the gradient pulse Gz suitable for satisfying both of the conditions (1) and (2).

  The time length of the sequence SQ3 can be several hundred msec (for example, 200 msec). As an example of the sequence SQ3, a DANTE sequence can be used. After performing phase dispersion by the sequence SQ3, the pulse set Inv2 is executed. The pulse set Inv2 is the same as the pulse set Inv1. Therefore, by executing the pulse set Inv2, similarly to the pulse set Inv1, the region R1 (see FIG. 13) is selectively excited, and the longitudinal magnetization of each tissue in the region R1 can be reversed. After applying the pulse set Inv2, the data acquisition sequence DAQi (corresponding to the third sequence) is executed. A waiting time is provided between the pulse set Inv2 and the data acquisition sequence DAQi. This waiting time is set so that the data acquisition sequence DAQi is started when the longitudinal magnetization of the background tissue has a value as close to zero as possible. By executing the data acquisition sequence DAQi, imaging data is acquired from the imaging region.

  The sequence segment Ai is configured as described above. In the present embodiment, the main scan MS includes m sequence segments A1 to Am. Accordingly, m data collection segments DAQ1 to DAQm are executed by executing the main scan MS. Each of the data collection segments DAQ1 to DAQm collects a part of k-space imaging data. In this embodiment, imaging data when labeling is performed is collected by the sequence segments A1 to An.

FIG. 19 is an explanatory diagram of signals obtained from the imaging region SB by executing the sequence segment Ai.
In the sequence segment Ai, the labeling sequence SQ2 performs blood spin labeling so that the longitudinal magnetization of blood in the labeling region SL is as small as possible. Therefore, by executing the labeling sequence SQ2, blood b0 having a small longitudinal magnetization flows out from the labeling region SL and flows into the imaging region SB. In the sequence segment Ai, the sequence SQ3 is executed after the labeling sequence SQ2 and before the data collection sequence DAQi. The sequence SQ3 is configured to sufficiently disperse the phase of blood (for example, blood b1) having a high flow rate in the region R2, although the phase of blood (for example, blood b2) having a low flow rate in the region R2 does not disperse very much. Has been. Therefore, before the data collection sequence DAQi is executed, the magnetization of the blood b1 flowing through the thick blood vessel can be further reduced.

  In the sequence segment Ai, since the pulse sets Inv1 and Inv2 for reducing the signal of the background tissue (for example, white matter and gray matter) are executed, before the data acquisition sequence DAQi is executed, Magnetization can also be reduced.

Thus, the labeling sequence SQ2 is executed in the sequence segment Ai. The labeling sequence SQ2 labels the spin of blood so that the longitudinal magnetization of the blood in the labeling region SL becomes sufficiently small. Accordingly, blood with a small longitudinal magnetization flows into the imaging region SB. Then, before the data collection sequence DAQi is executed, the sequence SQ3 is executed. By the sequence SQ3, the phase of the blood b1 flowing through the thick blood vessel is sufficiently dispersed. Further, the signals of the background tissue can be reduced by the pulse sets Inv1 and Inv2. Therefore, by executing the sequence segment Ai, imaging data is obtained in which the signal value of the blood b2 flowing through the thin blood vessel is relatively small and the signal value of the blood b1 flowing through the background tissue and the thick blood vessel is still smaller.
Next, the sequence segments B1 to Bm will be described.

FIG. 20 is an explanatory diagram of the sequence segments B1 to Bm.
In FIG. 20, the i-th sequence segment is indicated by Bi. i is an integer value of i = 1 to m. Therefore, for example, when i = 1, the sequence segment Bi represents the sequence segment B1, and when i = m, the sequence segment Bi represents the sequence segment Bm.

  The sequence segment Bi has a Pre Sat sequence SQ1, a control sequence SQ20, a pulse set Inv1, a sequence SQ3, a pulse set Inv2, and a data acquisition sequence DAQi. Hereinafter, these sequences and pulse sets will be described in order.

  The sequence segment Bi is different from the sequence segment Ai in that it includes a control sequence SQ20 instead of the labeling sequence SQ2, but the other sequences and pulse sets are the same as the sequence segment Ai. . Therefore, in describing the sequence segment Bi, the control sequence SQ20 will be mainly described.

FIG. 21 is an explanatory diagram of the control sequence SQ20.
The control sequence SQ20 (corresponding to the fourth sequence) is a sequence in which no magnetic labeling is performed on the spins of the blood b0 flowing through the labeling region SL. The control sequence SQ20 has pulse sets E1 and E2. The pulse set E1 and the pulse set E2 are executed alternately. The pulse set E1 is the same as the pulse set E1 (see FIG. 11) of the labeling sequence SQ2. Therefore, the description of the pulse set E1 is omitted, and the pulse set E2 will be described.

  The pulse set E2 includes an RF pulse P22, a slice selection pulse Gs2, and a correction gradient pulse Gc2. A coordinate system (b) for explaining the phase φb of the RF pulse P22 is shown on the lower side of FIG. The z-axis represents the static magnetic field direction. Here, the axis (φb axis) representing the phase φb of the RF pulse P22 is set to the −x axis (axis shifted by 180 ° with respect to the x axis).

  The RF pulse P22 has the same flip angle β as that of the RF pulse P21. Therefore, when the RF pulse P22 is applied, the magnetization vector rotates about the φb axis (−x axis) by the flip angle β. For example, when β = 12 °, the magnetization vector M rotates β = 12 ° around the axis of the φb axis.

  The labeling region SL is excited by the RF pulse P22 and the slice selection pulse Gs2. Immediately after the excitation of the labeling region SL, a correction gradient pulse Gc2 for returning the spin phase shift is applied.

  By executing the pulse set E2, the magnetization vector of the blood b0 in the labeling region SL can be flipped by the flip angle β.

FIG. 22 is an explanatory diagram of the operation of the control sequence SQ20.
FIG. 22 schematically shows a coordinate system (c) for explaining the magnetization vector M of the blood b0 in the labeling region SL immediately before the start of the control sequence SQ20. Immediately before the start of the control sequence SQ20, the magnetization vector M of the blood b0 in the labeling region SL is assumed to be in the z-axis direction.

  When the pulse set E1 is executed, the magnetization vector M of the blood b0 in the labeling region SL is flipped by β around the axis φa by the RF pulse P21 (see the coordinate system (a)). Therefore, the magnetization vector M is inclined by β with respect to the z-axis. After the pulse set E1 is executed, the next pulse set E2 is executed.

  When the pulse set E2 is executed, the magnetization vector M of the blood b0 in the labeling region SL is flipped by β around the axis φb by the RF pulse P22 (see coordinate system (b)). Therefore, the magnetization vector M returns from the position inclined by β with respect to the z axis to the position on the z axis.

  Similarly, pulse sets E1 and E2 are executed alternately. Therefore, the magnetization vector M of the blood b0 in the labeling region SL is inclined by β with respect to the z axis by the RF pulse P21 of the pulse set E1, but returns to the position on the z axis by the RF pulse P22 of the pulse set E2.

  As described above, in the control sequence SQ20, the pulse sets E1 and E2 are alternately executed. Therefore, even if the magnetization vector M of the blood b0 in the labeling region SL is inclined by β with respect to the z axis, the z axis is immediately Return to the upper position. Therefore, by executing the control sequence SQ20, the spin of the blood b0 in the labeling region SL is not labeled, and the blood b0 having a sufficiently large longitudinal magnetization flows out from the labeling region SL. The time length of the control sequence SQ20 can be several seconds (for example, 2 seconds). After executing the control sequence SQ20, the pulse set Inv1, the sequence SQ3 (corresponding to the fifth sequence), the pulse set Inv2, and the data acquisition sequence DAQi (corresponding to the sixth sequence) are similar to the sequence segment Ai. It is executed in order.

  The sequence segment Bi is configured as described above. In the present embodiment, the main scan MS includes m sequence segments B1 to Bm. Imaging data when labeling is not performed is collected by the sequence segments B1 to Bm.

FIG. 23 is an explanatory diagram of signals obtained from the imaging region SB by executing the sequence segment Bi.
In the sequence segment Bi, the control sequence SQ20 does not label the spin of blood in the labeling region SL, and prevents longitudinal magnetization from becoming as small as possible. Therefore, by executing the control sequence SQ20, the blood b0 having a large longitudinal magnetization flows out from the labeling region SL and flows into the imaging region SB. In the sequence segment Bi, after the control sequence SQ20 is executed, the sequence SQ3 is executed before the data collection sequence DAQi. The sequence SQ3 is configured to sufficiently disperse the phase of blood (for example, blood b1) having a high flow rate in the region R2, although the phase of blood (for example, blood b2) having a low flow rate in the region R2 does not disperse very much. Has been. Therefore, before the data acquisition sequence DAQi is executed, the magnetization of the blood b2 flowing through the thin blood vessel can be made sufficiently larger than the magnetization of the blood b1 flowing through the thick blood vessel.

  Further, in the sequence segment Bi, the pulse sets Inv1 and Inv2 for reducing the signal of the background tissue (for example, white matter and gray matter) are executed. Therefore, before the data acquisition sequence DAQi is executed, Magnetization can also be reduced.

  Thus, the control sequence SQ20 is executed in the sequence segment Bi. The control sequence SQ20 prevents the longitudinal magnetization of blood in the labeling region SL from becoming as small as possible. Therefore, blood with a large longitudinal magnetization flows into the imaging region SB. Then, before the data collection sequence DAQi is executed, the sequence SQ3 is executed. By the sequence SQ3, the phase of the blood b1 flowing through the thick blood vessel is sufficiently dispersed. Further, the signals of the background tissue can be reduced by the pulse sets Inv1 and Inv2. Therefore, by executing the sequence segment Bi, imaging data in which the signal value of the blood b2 flowing through the thin blood vessel is larger than the signal value of the blood b1 flowing through the background tissue and the thick blood vessel is obtained.

  Therefore, in this embodiment, by executing the main scan MS, it is possible to obtain imaging data by the sequence segment Ai and imaging data by the sequence segment Bi. As described above, in the imaging data obtained in the sequence segment Ai, not only the signal value of the blood b1 flowing through the background tissue and the thick blood vessel but also the signal value of the blood b2 flowing through the thin blood vessel is small (see FIG. 19). On the other hand, in the imaging data obtained in the sequence segment Bi, the signal value of the blood b2 flowing through the thin blood vessel is sufficiently larger than the signal value of the blood b1 flowing through the background tissue and the thick blood vessel (see FIG. 23). Therefore, by subtracting the imaging data of the sequence segments Ai and Bi, the signal of the blood b2 is not canceled, but the signal value of the background tissue can be canceled, and the signal value of the blood b1 flowing through the thick blood vessel is also canceled. can do. For this reason, it is possible to obtain a high-quality perfusion image in which the signal of blood b1 flowing through a thin blood vessel is sufficiently larger than that of blood b1 flowing through a background tissue and a thick blood vessel.

  Below, an example of the flow performed in order to produce | generate a perfusion image in step ST4 is demonstrated.

FIG. 24 is an explanatory diagram of an example of the flow of step ST4.
In step ST41, the main scan MS is executed. When executing the main scan MS, the control unit 5 (see FIG. 1) includes RF pulse data (flip angle information (0 ° <α _i <90 °), etc.) of the sequence segments A1 to Am and B1 to Bm. Data) is sent to the transmitter 6, and gradient pulse data (data including information on the area of the gradient pulse) of the sequence segments A 1 to Am and B 1 to Bm is sent to the gradient magnetic field power source 7. The transmitter 6 supplies current to the RF coil 24 based on the data received from the control unit 5, and the gradient magnetic field power supply 7 supplies current to the gradient coil 23 based on the data received from the control unit 5. Therefore, the RF coil 24 applies an RF pulse, and the gradient coil 23 applies a gradient pulse. By executing the main scan MS, an MR signal is generated from the imaging region SB. The MR signal is received by the receiving coil 4 (see FIG. 1). The receiving coil 4 receives the MR signal and outputs an analog signal including information on the MR signal. The receiver 8 performs signal processing such as detection on the signal received from the receiving coil 4, and outputs data obtained by the signal processing to the processing device 9.

  Therefore, imaging data for reconstructing an image can be obtained for each of the sequence segments A1 to Am and B1 to Bm. FIG. 25 schematically shows imaging data obtained by the main scan MS. In FIG. 25, the imaging data obtained by the sequence segment Ai is indicated by DAi (i = 1 to m), while the imaging data obtained by the sequence segment Bi is indicated by DBi (i = 1 to m). Has been. After executing the main scan MS, the process proceeds to step ST42.

FIG. 26 is an explanatory diagram of step ST42.
In step ST42, the image generation means 91 performs a difference transformation between the imaging data DAi and the imaging data DBi, and Fourier transforms the difference data DIi. Thereby, a perfusion image of the imaging region SB can be obtained.

  As described above, in this embodiment, the sequence SQ3 is used. By using the sequence SQ3, there is an effect that a high-quality perfusion image can be obtained. Hereinafter, the reason why a high-quality perfusion image can be obtained by using the sequence SQ3 will be described. In order to explain this reason, an example of a segment that does not use the sequence SQ3 (hereinafter referred to as “comparative example”) will be described below, and the difference between the comparative example and this embodiment will be clarified. The effect of sequence SQ3 will be described.

  FIG. 27 is a diagram showing a sequence segment Ai of this embodiment and a sequence segment Ai of a comparative example, and FIG. 28 is a diagram showing a sequence segment Bi of this embodiment and a sequence segment Bi of a comparative example. First, FIG. 27 will be described.

  Referring to FIG. 27, the sequence segment Ai of the comparative example does not include the sequence SQ3, but includes the Inf Sat sequence SQ31 instead of the sequence SQ3. A DWDE (diffusion-weighted driven-equilibrium) sequence SQ35 is provided immediately before the data collection sequence DAQi.

  The Inf Sat sequence SQ31 is a sequence for reducing the longitudinal magnetization of blood flowing in the region R3 sandwiched between the labeling region SL and the imaging region SB. The DWDE sequence SQ35 has RF pulses (90 ° pulse and 180 ° pulse) and gradient pulses (G1, G2, and G3). The DWDE sequence SQ35 is a sequence configured such that the magnetization of blood with a low flow rate is not as small as possible, but the magnetization of blood with a high flow rate is as small as possible.

  Next, FIG. 28 will be described. FIG. 28 is a diagram illustrating a sequence segment Bi of the present embodiment and a sequence segment Bi of a comparative example.

  Referring to FIG. 28, the sequence segment Bi of the comparative example does not include the sequence SQ3, but includes the Inf Sat sequence SQ31 instead of the sequence SQ3. A DWDE sequence SQ35 is provided immediately before the data collection sequence DAQi.

  The imaging data DAi and DBi (see FIG. 25) can be obtained by executing the sequence segments Ai and Bi of the comparative example instead of the sequence segments Ai and Bi in the present embodiment. Therefore, by obtaining difference data between the imaging data DAi and DBi and performing Fourier transform on the difference data, a perfusion image in which the signal of the blood b1 flowing through the thin blood vessel is larger than the blood b2 flowing through the background tissue and the thick blood vessel is obtained. Can do. However, when the sequence segments Ai and Bi of the comparative example are used, there are the following problems.

FIG. 29 is an explanatory diagram of problems in the comparative example.
In the comparative example, the DWDE sequence SQ35 is executed before the data collection sequence DAQi. The DWDE sequence SQ35 has a 90 ° pulse and a 180 ° pulse. Therefore, when the 90 ° pulse of the DWDE sequence SQ35 is applied, the blood spin should ideally be flipped by 90 ° in any part of the imaging region SB. However, in reality, due to the non-uniformity of B1, in the imaging region SB, the spin of blood does not always flip 90 °, and there are some that flip by an angle smaller than 90 ° (for example, 80 °), Some flip by an angle greater than 90 ° (eg, 100 °). For example, as shown in the lower side of FIG. 29, a 90 ° pulse was applied, but in the regions r1, r2, r3, and r4, the actual flip angles were 90 °, 80 °, 100 °, and 100 °, respectively. May be.

  When the 180 ° pulse of the DWDE sequence SQ35 is applied, the blood spin should ideally be flipped by 180 ° in any part of the imaging region SB. However, in reality, due to the non-uniformity of B1, in the imaging region SB, the spin of blood does not always flip 180 °, and there are some that flip by an angle smaller than 180 ° (for example, 160 °), Some flip by an angle greater than 180 ° (eg, 200 °). For example, as shown in the lower side of FIG. 29, a 180 ° pulse was applied, but in the regions r1, r2, r3, and r4, the actual flip angles were 180 °, 160 °, 200 °, and 200 °, respectively. May be. Accordingly, there is a problem that in the imaging region SB, variation in actual flip angle becomes large due to nonuniformity of B1, and it is difficult to obtain a uniform suppression effect on the signal of blood b1 in the imaging region SB.

On the other hand, in this embodiment, the DWDE sequence SQ35 is not used and the sequence SQ3 is used. In the sequence SQ3, the flip angle α _i of the RF pulse is set so as to satisfy 0 ° <α _i <90 °. For example, α _i = 12 °. Therefore, the flip angle α _i of the RF pulse of sequence SQ3 is set to a value smaller than the flip angle (90 ° and 180 °) of the RF pulse of DWDE sequence SQ35. For this reason, in this embodiment, since the variation of the flip angle in the imaging region SB due to the nonuniformity of B1 can be reduced, the signal of the blood b1 can be suppressed as uniformly as possible in the imaging region SB.

  Further, the area of the gradient pulse Gz in the sequence SQ3 is set so that the phase of the blood b2 having a low flow rate is not dispersed as much as possible, and the phase of the blood b1 having a high flow rate is dispersed as much as possible. Therefore, when the sequence segment Bi is executed, the blood b2 having a low flow rate can be made to have a sufficiently higher signal than the blood b1 having a high flow rate. For this reason, the imaging data DAi obtained by the sequence segment Ai and the imaging data DBi obtained by the sequence segment Bi are subtracted, and a high-quality perfusion image can be obtained by Fourier transforming the difference data.

Further, in this embodiment, the RF pulse w _i of the sequence SQ3 phase is set so as to satisfy the equation (1). Therefore, the phase of the RF pulse w _i increases by Δφ. By increasing the phase of the RF pulse w _i by Δφ, artifacts appearing in the perfusion image can be reduced. Note that the phase of the RF pulse w _i may be randomly changed without increasing the phase of the RF pulse w _{i in} the sequence SQ3 by Δφ. However, when the RF pulse w _i is randomly changed, it may be difficult to reduce artifacts appearing in the perfusion image. Therefore, it is desirable to set the phase of the RF pulse w _i so as to satisfy Expression (1).

  In this embodiment, the sequence SQ3 is provided between the pulse sets Inv1 and Inv2. However, the sequence SQ3 is not necessarily provided between the pulse sets Inv1 and Inv2. FIG. 30 is a diagram illustrating an example in which the sequence SQ3 is not provided between the pulse sets Inv1 and Inv2, but is provided between the pulse set Inv2 and the data acquisition sequence DAQi. In FIG. 30, an Inf Sat sequence SQ31 (corresponding to the seventh sequence) is provided between the pulse sets Inv1 and Inv2 in the sequence segment Ai. In the sequence segment Bi, the pulse set Inv1 and Between Inv2, an Inf Sat sequence SQ31 (corresponding to an eighth sequence) is provided. Also in FIG. 30, since the sequence SQ3 is used, it is possible to obtain a perfusion image in which variation in the blood flow suppression effect is reduced.

  In this embodiment, each of sequence segments Ai and Bi has one sequence SQ3. However, two or more sequences SQ3 may be included in each of the sequence segments Ai and Bi. FIG. 31 shows an example in which two sequences SQ3 are included in each of the sequence segments Ai and Bi. By providing a plurality of sequences SQ3 in each of the sequence segments Ai and Bi, a higher quality perfusion image can be obtained.

  In this embodiment, the pulse sets Inv1 and Inv2 have a gradient pulse Gin to selectively excite the region R1 (see FIG. 13). However, the region R1 may be excited non-selectively using only the RF pulse Pin without providing the gradient pulse Gin. In this embodiment, the RF pulse Pin is a 90 ° pulse, but an RF pulse different from the 90 ° pulse (for example, an 85 ° pulse) may be used as long as the background tissue signal can be reduced. Furthermore, if sufficient quality perfusion images can be obtained, the pulse sets Inv1 and / or Inv2 need not be provided.

  In this embodiment, the perfusion image is obtained by subtracting the imaging data DAi obtained by the sequence segment Ai and the imaging data DBi obtained by the sequence segment Bi, and Fourier-transforming the difference data. However, the imaging data DAi obtained by the sequence segment Ai is Fourier-transformed to generate an image a, and the imaging data DBi obtained by the sequence segment Bi is Fourier-transformed to generate an image b. A perfusion image may be obtained by subtracting the image b.

The flip angles α _{1 to} α _n (see FIG. 14) of the RF pulse used in the sequence SQ3 of this embodiment may be set to the same value as long as the condition of 0 ° <α _i <90 ° is satisfied. It may be set to a different value. However, in order to obtain a higher quality perfusion image, it is desirable that the flip angles α _{1 to} α _n have the same value. α _i can be set to an angle between 7 ° and 12 °, for example. In order to obtain a higher-quality perfusion image, the flip angle α _i of the RF pulse of the sequence SQ3 of the sequence segment Ai is set to the same value as the flip angle α _i of the RF pulse of the sequence SQ3 of the sequence segment Bi. It is desirable. However, if a perfusion image of sufficient quality is obtained, the flip angle α _i of the RF pulse of the sequence SQ3 of the sequence segment Ai is not necessarily the same value as the flip angle α _i of the RF pulse of the sequence SQ3 of the sequence segment Bi. Not necessarily.

  In this embodiment, the main scan MS is executed so that the sequence segment Ai and the sequence segment Bi appear alternately. However, the order of sequence segment Ai and sequence segment Bi is not limited to the order in which sequence segment Ai and sequence segment Bi appear alternately, and any order is possible. For example, the sequence segments B1 to Bm may be executed after the sequence segments A1 to Am are executed.

In this embodiment, the RF pulse w _i of the pulse set V _i of the sequence SQ3 is a non-selection pulse, and the region R2 (see FIG. 14) is excited using the RF pulse w _i of the non-selection pulse. However, the RF pulse w _i may be a selection pulse for selectively exciting the region R2. Further, if it is possible to obtain a sufficient quality of the perfusion image, the imaging area SB is excited, the labeling region SL is not to excite, it is also possible to configure the RF pulse w _i.

DESCRIPTION OF SYMBOLS 1 MR apparatus 2 Magnet 3 Table 3a Cradle 4 Receiving coil 5 Control part 6 Transmitter 7 Gradient magnetic field power supply 8 Receiver 9 Processing apparatus 10 Memory | storage part 11 Operation part 12 Display part 13 Subject 21 Storage space 22 Superconducting coil 23 Gradient coil 24 RF coil 91 Image generation means 92 Setting means

Claims (9)

A magnetic resonance apparatus for acquiring an image of a first region containing blood,
Setting means for setting a second region for labeling the spin of blood before blood flows into the first region;
Scanning means for executing an imaging sequence for acquiring an image of the first region,
A first sequence for labeling spins of blood in the second region;
A second sequence executed after the first sequence, the first RF pulse for exciting the first region and the phase of the spin of the first blood flowing through the first region To disperse the spin phase of the blood in the first region so that the spin phase of the second blood flowing through the first region at a slower flow rate than the first blood is dispersed. A second sequence having a plurality of first pulse sets including a first gradient pulse of:
A third sequence for collecting data of the first region after the second sequence is executed;
A first sequence segment that includes: a fourth sequence that does not label spins of blood in the second region;
A fifth sequence executed after the fourth sequence, the second RF pulse for exciting the first region and the phase of spin of the third blood flowing in the first region; To disperse the spin phase of the blood in the first region so that the spin phase of the fourth blood flowing through the first region at a slower flow rate than the third blood is dispersed. A fifth sequence having a plurality of second pulse sets including a second gradient pulse;
A sixth sequence for collecting data of the first region after the fifth sequence is executed;
A second sequence segment containing
Scanning means for executing an imaging sequence comprising:
A control unit for controlling the scanning means;
Image generating means for generating an image of the first region based on data obtained by executing the imaging sequence;
Have
The controller is
In the first sequence segment, the flip angle of the first RF pulse of each of the plurality of first pulse sets included in the second sequence has a value greater than 0 ° and less than 90 °;
In the second sequence segment, the flip angle of the second RF pulse of each of the plurality of second pulse sets included in the fifth sequence has a value larger than 0 ° and smaller than 90 °. A magnetic resonance apparatus for controlling the scanning means. The controller is
The scanning means such that the first RF pulses of the plurality of first pulse sets have the same flip angle and the second RF pulses of the plurality of second pulse sets have the same flip angle. The magnetic resonance apparatus according to claim 1, wherein the magnetic resonance apparatus is controlled. The controller is
The magnetic resonance apparatus according to claim 2, wherein the scanning unit is controlled such that a flip angle of the first RF pulse and a flip angle of the second RF pulse are the same. The controller is
Among the plurality of first pulse sets, the phase φ _i of the first RF pulse included in the first pulse set executed i-th has a value represented by the following equation: The magnetic resonance apparatus according to claim 3, wherein the scanning unit is controlled.

φ _i = φ ₁ + (i−1) Δφ
Here, φ ₁ : the phase of the first RF pulse included in the first pulse set executed first
Δφ: Phase of the first RF pulse included in the first pulse set executed i−1 and phase of the first RF pulse included in the first pulse set executed i And phase difference The controller is
Of the plurality of second pulse sets, the phase φ _i of the second RF pulse included in the i-th executed second pulse set has a value represented by the following equation: The magnetic resonance apparatus according to claim 4, wherein the scanning unit is controlled.

φ _i = φ ₁ + (i−1) Δφ
Here, φ ₁ : phase of the second RF pulse included in the second pulse set executed first
Δφ: phase of the second RF pulse included in the second pulse set executed i−1 and phase of the second RF pulse included in the second pulse set executed i And phase difference The controller is
An RF pulse for reducing the longitudinal magnetization of the background tissue of the first region is applied between the first sequence and the second sequence, and
The scanning means is controlled so that an RF pulse for reducing the longitudinal magnetization of the background tissue of the first region is applied between the fourth sequence and the fifth sequence. The magnetic resonance apparatus according to any one of 1 to 5. The controller is
An RF pulse for reducing the longitudinal magnetization of the background tissue of the first region is applied between the second sequence and the third sequence, and
The scanning means is controlled so that an RF pulse for reducing the longitudinal magnetization of the background tissue in the first region is applied between the fifth sequence and the sixth sequence. The magnetic resonance apparatus according to any one of 1 to 6. The controller is
A seventh sequence for reducing longitudinal magnetization of blood flowing in a third region between the first region and the second region between the first sequence and the second sequence Is executed,
Controlling the scanning means so that an eighth sequence for reducing longitudinal magnetization of blood flowing through the third region is executed between the fourth sequence and the fifth sequence; The magnetic resonance apparatus according to claim 1. The magnetic field according to claim 1, wherein the first RF pulse and the second RF pulse excite a region including the first region and the second region. Resonator.